Genetically engineered T cells for the treatment of cancer

por Essand, M, Loskog, A S I
Publicado 2013

A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer

por Mansoori, S., Fryknäs, M., Alvfors, C., Loskog, A., Larsson, R., Nygren, P.
Publicado 2021

Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients

por Schiza, A., Wenthe, J., Mangsbo, S., Eriksson, E., Nilsson, Anders, Tötterman, T. H., Loskog, A., Ullenhag, G.
Publicado 2017

Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

por Amini, R-M, Enblad, G., Hollander, P., Laszlo, S., Eriksson, E., Ayoola Gustafsson, K., Loskog, A., Thörn, I.
Publicado 2019

Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment

por Eriksson, E, Moreno, R, Milenova, I, Liljenfeldt, L, Dieterich, L C, Christiansson, L, Karlsson, H, Ullenhag, G, Mangsbo, S M, Dimberg, A, Alemany, R, Loskog, A
Publicado 2017